Compared to diet alone, in the group of 342 newly diagnosed overweight patients with T2DM treated with metformin, MI was reduced by 39%, coronary deaths by 50%, stroke by 41%, and all-cause mortality by 36% after a median 10.7 years (14)
Canagliflozin significantly inhibits inflammatory factor expression, including cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase, exerting cardioprotective effects by regulating inflammation and ferroptosis through the AMP-activated protein kinase (AMPK) pathway (83)
Pale yellow indicates adequate hydration
Targeted supplements: Data indicates that calorie intake reduces by 16-39% while taking a GLP1 medication (Spreckley 2026)
Semaglutide users who took a weekly dose of 2.4 mg for 68 weeks, or roughly 15 months, dropped an average of 35 pounds, or 15% of their body weight, compared to 2.4% for the placebo group